Abstract Supplement ventilator-dependent patients and one for spontaneously breathing patients. Correction factors for gender, the presence of additional trauma, and obesity are indicated on the graphical calculators.
INTRODUCTION:
The aim of this study was to assess the efficacy and safety of topical timolol 0.5% drops in healing chronic refractory ulcers of various etiologies in a large patient cohort.
METHODS:
From January to June 2016 we recruited 82 consecutive patients affected by nonhealing loss of substance associated to diverse etiologies (venous, diabetic, post-surgery, postradiation, pressure, mistreated burns) . All lesions were chronic, had been present for at least 3 months. All patients had been treated with the appropriate standard of care with no therapeutic response. All patients were > 18 year old. Each patient was treated with topical timolol drops 0.5% (1 drop every 2 cm of wound area\day for 6 weeks), then covered with polyurethane film and 3 layers of dressings. Objective assessment was carried out through wound area tracing at baseline, at 6 weeks of therapy, and at the 6 month followup. 10 patients underwent assessment of timolol plasma levels concentration at 6 weeks. Adverse events were recorded at each time point.
RESULTS:
A statistical significant improvement in % of area reduction (up to 98.75%) and mean size was noted in every group except diabetic and pressure ulcers. The mean area reduction in % persisted or improved at 6 months in all groups, except diabetic and pressure ulcers, which tended to recur. VAS scale documented good to excellent patient satisfaction in every group except the diabetic and pressure ones. 6 patients developed contact dermatitis. No patient presented cardiologic parameters abnormalities; timolol plasma levels were undetectable in the 10 assessed patients.
CONCLUSION:
Few reports have documented the efficacy of topical beta-blockers in chronic and treatment-refractory ulcers.
1-4 At present there is a noticeable lack of randomized controlled evidence in the international literature. To date, this represents the most comprehensive experience in terms of patients numbers and type of loss of substance documenting the use of topical betablockers in wound healing. We obtained satisfactory results in every group with the exception of diabetic and pressure ulcers, which responded poorly at 6 weeks and had a tendency to recur. Adverse effects were mild to moderate and required no dose adjustment, with the exception of 1 patient that was forced to give up treatment. Specific dosage and application protocols need to be optimized by further observations. and masseter muscle. While, the mean volume of the buccal fat pat is approximately 10 ml, the main physiological function of the buccal fat pad is to fill the masticatory space and act as a cushion for the masticatory muscles. There have been studies on the use of the pedicled buccal fat pad for closure of oroantral or oronasal communications secondary to exodontias and for postsurgical oral defects for malignant lesions. In the fields of aesthetic surgery, the major reason for manipulating the buccal fat pad is to extract these fatty tissues in order to reduce prominent cheeks. Using the buccal fat pads to restore softtissue volume for volume-deficient areas is limitedly carried out by using the fat pads in a free graft method. Meanwhile, deficient soft-tissue volume in the malar and midface region causes a broad and flat facial appearance and often is related with the aging process which results in an old-or tired-look. By utilizing the buccal fat pads to the adjacent volume-deficient malar regions, a volume restoring and rejuvenating effect can be easily achieved. As the fat pads can be mobilized as a vascularized flap, concerns on volume resorption that is commonly noticed after conventional free fat transfer methods can be avoided. Also, the use of soft-tissue fillers or alloplastic implants can be avoided. Thus, longterm stability can be assured and its procedural simplicity, with very low complication rates and natural-looking results, encourage surgeons to use the pedicled buccal fat pad as a tool for malar and midface augmentation. This procedure can be easily combined with a reduction malarplasty procedure, as patients with laterally prominent zygomatic bones usually have deficient volume in the anterior malar region. While the lateral projections of the zygoma are reduced by reduction malarplasty, anterior malar volume can be restored concomitantly by utilizing the pedicled buccal fat pad through the same intraoral approach. The buccal fat pad is gently delivered atraumatically using non-toothed forceps from the masticatory space by blunt dissection while keeping the fascial envelope intact. The mobilized buccal fat pad then is fixed to the volumedeficient area with resorbable sutures.
Awareness of Breast Asymmetry by Women with Hypoplastic Breasts
Presenter: Norma I. Cruz, MD Affiliation: University of Puerto Rico, San Juan, PR INTRODUCTION: Breast asymmetry is highly prevalent among women with hypoplastic breasts, currently being reported in 88% to 100% of cases.
1-4 However, the frequency of patient's awareness of asymmetry has not been compared to the frequency of clinically measured asymmetry.
METHODS:
Consecutive women with hypoplastic breasts who were considering primary breast augmentation between 12/1/2013 and 12/1/2016 were evaluated. The women were requested, while looking at themselves in the mirror, to report any pre-existing asymmetry of the breasts in four specific areas. The areas evaluated were; the nippleareola complex, breast mound, inframammary fold and chest wall. The women were examined and breast measurements were performed by the same surgeon and prospectively recorded. A discrepancy greater than 5 mm in distance or greater than 20 ml in volume between the breast measurements was considered as evidence of asymmetry, since it has been reported that smaller differences can hardly be noticed by the naked eye.
3 Comparison between patient-reported breast asymmetry and measured asymmetry was performed. Differences between proportions were compared using the Chi-square test. Results were considered significant when the p value was less than 0.05. This study was approved by the Institutional Review Board.
RESULTS:
The study evaluated 173 consecutive women with hypoplastic breasts. The mean age was 30 ± 9 years, the mean body mass index was 21 ± 2, and mean bra size was 34-A. Patient-reported asymmetry was significantly lower (p<0.05) than measured asymmetry in every category. The discrepancy between patient-reported breast asymmetry and measured asymmetry for the nipple-areola position was 24%, for the breast mound 21%, for the inframammary fold was 30% and for the chest wall was 11%. The most frequently missed breast asymmetry by patients was that of the inframammary fold. Overall, patients reported some asymmetry in 41% of the cases, while measured asymmetries were found in 95% of the cases, a difference that was statistically significant (p<0.05).
CONCLUSION:
There is a significant discrepancy between the frequency of patient-reported and measured preoperative breast asymmetry in women with hypoplastic breasts. Patients are often unaware of pre-existing breast asymmetry,
